TORONTO, December 30, 2025--(BUSINESS WIRE)--Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) ("Cybin" or the "Company"), a clinical-stage breakthrough neuropsychiatry company committed to ...

The program will remain effective until either all shares are issued and sold or until October 17, 2027, unless terminated earlier. The ATM program was established through a distribution agreement ...

Inhibikase Therapeutics ( (IKT)) has shared an announcement. On December 19, 2025, Inhibikase Therapeutics, Inc. filed a prospectus supplement with the U.S. Securities and Exchange Commission to ...

Cybin Inc. (NYSE American:CYBN) (Cboe Canada CA:CYBN) (“Cybin” or the “Company”), a clinical-stage breakthrough neuropsychiatry company committed to advancing mental healthcare by developing new and ...

SAB Biotherapeutics ( (SABS)) has provided an update. On December 29, 2025, SAB Biotherapeutics, Inc. entered into a new sales agreement with UBS Securities LLC to establish an at-the-market equity ...

Share prices will vary among purchasers based on market conditions at the time of sale. The ATM Program was established through a prospectus supplement dated December 30, 2025, to the company’s short ...

A whopping 54 individuals have been indicted for their roles in a conspiracy to deploy malware and commit ATM Jackpotting fraud. A federal grand jury in the District of Nebraska has returned two ...

Forbes contributors publish independent expert analyses and insights. I consult on marketing strategy, content creation, and messaging. The market is pricing Strategy (NASDAQ: MSTR), formerly ...

12 NEWS RIA SPIGNER TONIGHT WITH A TIP THAT LED TO AN ARREST. >> YOU’RE INSIDE RITCHIE’S BAR IN BIG BEND EARLY IN THE MORNING ON JUNE 4TH. WHEN THE SOUND OF BREAKING GLASS SHATTERS. THE SILENCE. A GUY ...

After market close on Tuesday, FuelCell said in a filing it entered into an amended sales agreement to increase the amount of shares that may be sold under its sales agreement to $200 million.